

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.16433109 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.16433109 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.69928778 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.69928778 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.32535152 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.61833401 |
| 7 | bile acid biosynthetic process (GO:0006699) | 5.61134942 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.54923900 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.54923900 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.54923900 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.35968900 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.31030129 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.27858700 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.15834829 |
| 15 | urea cycle (GO:0000050) | 5.10295251 |
| 16 | urea metabolic process (GO:0019627) | 5.10295251 |
| 17 | cysteine metabolic process (GO:0006534) | 5.10114683 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 4.96268166 |
| 19 | protein carboxylation (GO:0018214) | 4.90381191 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.90381191 |
| 21 | complement activation, alternative pathway (GO:0006957) | 4.89781945 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.86631967 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 4.83220617 |
| 24 | bile acid metabolic process (GO:0008206) | 4.81159200 |
| 25 | regulation of protein activation cascade (GO:2000257) | 4.77188740 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.70539779 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.67855488 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.59045858 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 4.55100471 |
| 30 | tyrosine metabolic process (GO:0006570) | 4.49137097 |
| 31 | regulation of complement activation (GO:0030449) | 4.49031565 |
| 32 | cellular ketone body metabolic process (GO:0046950) | 4.48589937 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.40910997 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.40771746 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.38617407 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.36399439 |
| 37 | lysine metabolic process (GO:0006553) | 4.31532761 |
| 38 | lysine catabolic process (GO:0006554) | 4.31532761 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.26144635 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.26144635 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.26144635 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.25170311 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.22447433 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.19795357 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.19795357 |
| 46 | coenzyme catabolic process (GO:0009109) | 4.17390473 |
| 47 | epoxygenase P450 pathway (GO:0019373) | 4.15873662 |
| 48 | glutamate metabolic process (GO:0006536) | 4.11586713 |
| 49 | bile acid and bile salt transport (GO:0015721) | 4.09928365 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.09340029 |
| 51 | phospholipid efflux (GO:0033700) | 4.02397112 |
| 52 | indolalkylamine metabolic process (GO:0006586) | 4.01063838 |
| 53 | cellular glucuronidation (GO:0052695) | 4.00326436 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 3.97608466 |
| 55 | cellular amino acid catabolic process (GO:0009063) | 3.96934907 |
| 56 | cholesterol efflux (GO:0033344) | 3.95860220 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 3.91672091 |
| 58 | negative regulation of sterol transport (GO:0032372) | 3.91672091 |
| 59 | ketone body metabolic process (GO:1902224) | 3.87467810 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 3.82694857 |
| 61 | amine catabolic process (GO:0009310) | 3.82694857 |
| 62 | drug catabolic process (GO:0042737) | 3.80664683 |
| 63 | ethanol oxidation (GO:0006069) | 3.77464690 |
| 64 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.77132485 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 3.72640816 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 3.72598266 |
| 67 | short-chain fatty acid metabolic process (GO:0046459) | 3.70650757 |
| 68 | acetyl-CoA metabolic process (GO:0006084) | 3.69488025 |
| 69 | astrocyte differentiation (GO:0048708) | 3.66797085 |
| 70 | glucuronate metabolic process (GO:0019585) | 3.59739156 |
| 71 | uronic acid metabolic process (GO:0006063) | 3.59739156 |
| 72 | regulation of bile acid biosynthetic process (GO:0070857) | 3.59503968 |
| 73 | low-density lipoprotein particle remodeling (GO:0034374) | 3.58458934 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 3.57890203 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.56843563 |
| 76 | fibrinolysis (GO:0042730) | 3.54386116 |
| 77 | arginine metabolic process (GO:0006525) | 3.53031575 |
| 78 | positive regulation of lipid catabolic process (GO:0050996) | 3.52570965 |
| 79 | organic acid catabolic process (GO:0016054) | 3.50066341 |
| 80 | carboxylic acid catabolic process (GO:0046395) | 3.50066341 |
| 81 | regulation of cholesterol homeostasis (GO:2000188) | 3.47714965 |
| 82 | phospholipid homeostasis (GO:0055091) | 3.46068551 |
| 83 | cofactor catabolic process (GO:0051187) | 3.45720491 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.45119108 |
| 85 | drug transmembrane transport (GO:0006855) | 3.44573547 |
| 86 | aldehyde catabolic process (GO:0046185) | 3.43360333 |
| 87 | nucleobase catabolic process (GO:0046113) | 3.41312024 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.40248526 |
| 89 | glycine metabolic process (GO:0006544) | 3.38874586 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.38613267 |
| 91 | omega-hydroxylase P450 pathway (GO:0097267) | 3.37723219 |
| 92 | complement activation, classical pathway (GO:0006958) | 3.37042534 |
| 93 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.36711405 |
| 94 | cytolysis (GO:0019835) | 3.35463991 |
| 95 | complement activation (GO:0006956) | 3.35072415 |
| 96 | sterol homeostasis (GO:0055092) | 3.35060776 |
| 97 | very long-chain fatty acid metabolic process (GO:0000038) | 3.34775833 |
| 98 | exogenous drug catabolic process (GO:0042738) | 3.34681312 |
| 99 | aspartate family amino acid catabolic process (GO:0009068) | 3.33906146 |
| 100 | monocarboxylic acid catabolic process (GO:0072329) | 3.31813517 |
| 101 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.30905302 |
| 102 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.29422543 |
| 103 | fatty acid oxidation (GO:0019395) | 3.28698599 |
| 104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27907247 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27907247 |
| 106 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.27738465 |
| 107 | regulation of cell communication by electrical coupling (GO:0010649) | 3.17166624 |
| 108 | detection of calcium ion (GO:0005513) | 3.01787462 |
| 109 | polyketide metabolic process (GO:0030638) | 2.96159516 |
| 110 | doxorubicin metabolic process (GO:0044598) | 2.96159516 |
| 111 | daunorubicin metabolic process (GO:0044597) | 2.96159516 |
| 112 | C4-dicarboxylate transport (GO:0015740) | 2.94701528 |
| 113 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.89134025 |
| 114 | carnitine metabolic process (GO:0009437) | 2.84707842 |
| 115 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.82977609 |
| 116 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.81885936 |
| 117 | positive regulation of glycolytic process (GO:0045821) | 2.81594698 |
| 118 | cellular potassium ion homeostasis (GO:0030007) | 2.80913562 |
| 119 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.74789613 |
| 120 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.74173645 |
| 121 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.73880489 |
| 122 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.71709414 |
| 123 | regulation of protein glycosylation (GO:0060049) | 2.67628706 |
| 124 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.67602191 |
| 125 | * macroautophagy (GO:0016236) | 2.67120003 |
| 126 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.66989923 |
| 127 | presynaptic membrane assembly (GO:0097105) | 2.66559253 |
| 128 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.64178208 |
| 129 | fructose metabolic process (GO:0006000) | 2.63648405 |
| 130 | drug metabolic process (GO:0017144) | 2.60002889 |
| 131 | sodium ion export (GO:0071436) | 2.59359052 |
| 132 | cellular sodium ion homeostasis (GO:0006883) | 2.58742058 |
| 133 | flavonoid metabolic process (GO:0009812) | 2.49843523 |
| 134 | negative regulation of neurotransmitter transport (GO:0051589) | 2.48637817 |
| 135 | photoreceptor cell differentiation (GO:0046530) | 2.46259481 |
| 136 | eye photoreceptor cell differentiation (GO:0001754) | 2.46259481 |
| 137 | presynaptic membrane organization (GO:0097090) | 2.45514739 |
| 138 | cell communication by electrical coupling (GO:0010644) | 2.44241821 |
| 139 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.39929536 |
| 140 | Notch signaling involved in heart development (GO:0061314) | 2.39202879 |
| 141 | oxidative demethylation (GO:0070989) | 2.37932730 |
| 142 | regulation of relaxation of muscle (GO:1901077) | 2.35045381 |
| 143 | cell communication involved in cardiac conduction (GO:0086065) | 2.34031050 |
| 144 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.32508672 |
| 145 | postsynaptic membrane organization (GO:0001941) | 2.32415042 |
| 146 | regulation of actin filament-based movement (GO:1903115) | 2.32262240 |
| 147 | glycoside metabolic process (GO:0016137) | 2.30957912 |
| 148 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.28684692 |
| 149 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.27704391 |
| 150 | sodium ion homeostasis (GO:0055078) | 2.24237473 |
| 151 | suckling behavior (GO:0001967) | 2.23856911 |
| 152 | carnitine shuttle (GO:0006853) | 2.22360005 |
| 153 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.22065186 |
| 154 | neuron cell-cell adhesion (GO:0007158) | 2.21929733 |
| 155 | acidic amino acid transport (GO:0015800) | 2.19850284 |
| 156 | positive regulation of vascular permeability (GO:0043117) | 2.17268491 |
| 157 | phenylpropanoid metabolic process (GO:0009698) | 2.16287747 |
| 158 | activation of MAPKKK activity (GO:0000185) | 2.16016203 |
| 159 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.15061623 |
| 160 | L-amino acid import (GO:0043092) | 2.14969812 |
| 161 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.13357084 |
| 162 | glutamate receptor signaling pathway (GO:0007215) | 2.12212561 |
| 163 | astrocyte development (GO:0014002) | 2.12145720 |
| 164 | regulation of lipoprotein metabolic process (GO:0050746) | 2.11800882 |
| 165 | startle response (GO:0001964) | 2.11715992 |
| 166 | xenobiotic catabolic process (GO:0042178) | 2.11057696 |
| 167 | neuron recognition (GO:0008038) | 2.09729154 |
| 168 | hormone catabolic process (GO:0042447) | 2.08957914 |
| 169 | axonal fasciculation (GO:0007413) | 2.08161128 |
| 170 | glutamate secretion (GO:0014047) | 2.07177864 |
| 171 | androgen metabolic process (GO:0008209) | 2.05620429 |
| 172 | potassium ion homeostasis (GO:0055075) | 2.05561629 |
| 173 | peroxisome fission (GO:0016559) | 2.05237576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.13987607 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.58197324 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.47237039 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.36098057 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.32232930 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.21507750 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.50647334 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.49039737 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.47925816 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.70490968 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.98013217 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.80135629 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66697246 |
| 14 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.62235761 |
| 15 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57249105 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57188374 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.56413157 |
| 18 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.48598215 |
| 19 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48362788 |
| 20 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.46675445 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.46421038 |
| 22 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.43892780 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37454862 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37166168 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36901492 |
| 26 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33007015 |
| 27 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.31387568 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31063830 |
| 29 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.30296498 |
| 30 | TP53_16413492_ChIP-PET_HCT116_Human | 1.29589133 |
| 31 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.28796345 |
| 32 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27928588 |
| 33 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.26093622 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25868316 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24787365 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24778267 |
| 37 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.24608099 |
| 38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.23751064 |
| 39 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23741988 |
| 40 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22826019 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22540186 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22540186 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19740890 |
| 44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19042027 |
| 45 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19032723 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18327010 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15453009 |
| 48 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13587202 |
| 49 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13324465 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12220236 |
| 51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.12082147 |
| 52 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.11236075 |
| 53 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10929844 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10857104 |
| 55 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09971261 |
| 56 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.09740629 |
| 57 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09658644 |
| 58 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09526530 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09432629 |
| 60 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08487057 |
| 61 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08159663 |
| 62 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08073044 |
| 63 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07267369 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06938798 |
| 65 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06337603 |
| 66 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01588068 |
| 67 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01463793 |
| 68 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01348106 |
| 69 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00996257 |
| 70 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00262048 |
| 71 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00052435 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99375246 |
| 73 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98954134 |
| 74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98568392 |
| 75 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98116486 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97841423 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97604986 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97517500 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97485769 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96447584 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94594861 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93775202 |
| 83 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93672923 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93171583 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92856214 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88062285 |
| 87 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85648466 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84446917 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83197403 |
| 90 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81836519 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81101671 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80543733 |
| 93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79637303 |
| 94 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.78708878 |
| 95 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77395227 |
| 96 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77033217 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76980188 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 0.74188873 |
| 99 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74051776 |
| 100 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.73108213 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73073538 |
| 102 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.73035650 |
| 103 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.72667024 |
| 104 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.72653201 |
| 105 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.71295350 |
| 106 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71016102 |
| 107 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.70896123 |
| 108 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.69549395 |
| 109 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.69545549 |
| 110 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.69182144 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.68846914 |
| 112 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.68202476 |
| 113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.68113819 |
| 114 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.67256628 |
| 115 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.67070143 |
| 116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66986139 |
| 117 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.66431248 |
| 118 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.66430366 |
| 119 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.66241076 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 0.66056046 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.65806241 |
| 122 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.65582839 |
| 123 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.64356205 |
| 124 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.64197893 |
| 125 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.64087579 |
| 126 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.63832647 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.63750632 |
| 128 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.63550227 |
| 129 | AR_25329375_ChIP-Seq_VCAP_Human | 0.63409958 |
| 130 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.63372322 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.62879842 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.62161085 |
| 133 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.61911559 |
| 134 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.61770739 |
| 135 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.61562693 |
| 136 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.61350431 |
| 137 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.61297921 |
| 138 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.61228294 |
| 139 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.61218881 |
| 140 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.59729449 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 0.59438828 |
| 142 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.59299481 |
| 143 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.58985805 |
| 144 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.58757455 |
| 145 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.58757455 |
| 146 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.58463832 |
| 147 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.57725581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.94994336 |
| 2 | MP0005360_urolithiasis | 7.16694022 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.19552885 |
| 4 | MP0005365_abnormal_bile_salt | 5.92597667 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93770140 |
| 6 | MP0003252_abnormal_bile_duct | 3.83436233 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.62666372 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.41219944 |
| 9 | MP0002638_abnormal_pupillary_reflex | 3.08272079 |
| 10 | MP0003195_calcinosis | 3.04511998 |
| 11 | MP0005083_abnormal_biliary_tract | 2.92566149 |
| 12 | MP0009840_abnormal_foam_cell | 2.75723496 |
| 13 | MP0005332_abnormal_amino_acid | 2.74057807 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.54800152 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.45288240 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.42617177 |
| 17 | MP0005623_abnormal_meninges_morphology | 2.22505794 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.22240465 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.15215966 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.08810308 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.08510824 |
| 22 | MP0003868_abnormal_feces_composition | 2.00763318 |
| 23 | MP0000609_abnormal_liver_physiology | 1.94668858 |
| 24 | MP0003880_abnormal_central_pattern | 1.86511586 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.83362327 |
| 26 | MP0004484_altered_response_of | 1.77577255 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.62683281 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.60509722 |
| 29 | MP0002064_seizures | 1.60241354 |
| 30 | MP0003635_abnormal_synaptic_transmissio | 1.59433128 |
| 31 | MP0001486_abnormal_startle_reflex | 1.57799115 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.57190249 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55022725 |
| 34 | MP0004885_abnormal_endolymph | 1.52345416 |
| 35 | MP0001764_abnormal_homeostasis | 1.46675946 |
| 36 | MP0002063_abnormal_learning/memory/cond | 1.45204479 |
| 37 | MP0000778_abnormal_nervous_system | 1.44902294 |
| 38 | MP0009697_abnormal_copulation | 1.44047724 |
| 39 | MP0004215_abnormal_myocardial_fiber | 1.42123472 |
| 40 | MP0005451_abnormal_body_composition | 1.41877251 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.41750415 |
| 42 | MP0002272_abnormal_nervous_system | 1.39488420 |
| 43 | MP0005386_behavior/neurological_phenoty | 1.36994703 |
| 44 | MP0004924_abnormal_behavior | 1.36994703 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.35227156 |
| 46 | MP0000604_amyloidosis | 1.33760919 |
| 47 | MP0002009_preneoplasia | 1.33534884 |
| 48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.32991853 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.30711549 |
| 50 | MP0010678_abnormal_skin_adnexa | 1.29881461 |
| 51 | MP0003690_abnormal_glial_cell | 1.25758370 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.24773497 |
| 53 | MP0000749_muscle_degeneration | 1.24529424 |
| 54 | MP0009046_muscle_twitch | 1.24040434 |
| 55 | MP0000750_abnormal_muscle_regeneration | 1.23442083 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.22634874 |
| 57 | MP0002734_abnormal_mechanical_nocicepti | 1.22020290 |
| 58 | MP0009745_abnormal_behavioral_response | 1.20735766 |
| 59 | MP0003329_amyloid_beta_deposits | 1.20710389 |
| 60 | MP0002067_abnormal_sensory_capabilities | 1.19111485 |
| 61 | MP0002269_muscular_atrophy | 1.15662486 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.13314504 |
| 63 | MP0005647_abnormal_sex_gland | 1.12944115 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.12367424 |
| 65 | MP0003011_delayed_dark_adaptation | 1.09485557 |
| 66 | MP0004130_abnormal_muscle_cell | 1.02930657 |
| 67 | MP0002972_abnormal_cardiac_muscle | 1.02809174 |
| 68 | MP0004087_abnormal_muscle_fiber | 1.02006280 |
| 69 | MP0005408_hypopigmentation | 1.01317302 |
| 70 | MP0003186_abnormal_redox_activity | 1.00476999 |
| 71 | MP0002332_abnormal_exercise_endurance | 1.00359450 |
| 72 | MP0001440_abnormal_grooming_behavior | 0.98407521 |
| 73 | MP0005535_abnormal_body_temperature | 0.98191861 |
| 74 | MP0003634_abnormal_glial_cell | 0.97065637 |
| 75 | MP0009764_decreased_sensitivity_to | 0.96579075 |
| 76 | MP0002254_reproductive_system_inflammat | 0.95967545 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.94061159 |
| 78 | MP0000462_abnormal_digestive_system | 0.94029206 |
| 79 | MP0000598_abnormal_liver_morphology | 0.92896622 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 0.91892341 |
| 81 | MP0001502_abnormal_circadian_rhythm | 0.91517258 |
| 82 | MP0001661_extended_life_span | 0.90575261 |
| 83 | MP0005620_abnormal_muscle_contractility | 0.90098313 |
| 84 | MP0001501_abnormal_sleep_pattern | 0.88979956 |
| 85 | MP0001727_abnormal_embryo_implantation | 0.88439732 |
| 86 | MP0003787_abnormal_imprinting | 0.88032795 |
| 87 | MP0002971_abnormal_brown_adipose | 0.87981524 |
| 88 | MP0000003_abnormal_adipose_tissue | 0.87219800 |
| 89 | MP0002822_catalepsy | 0.86836123 |
| 90 | MP0004043_abnormal_pH_regulation | 0.86323393 |
| 91 | MP0000383_abnormal_hair_follicle | 0.85783613 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.85554763 |
| 93 | MP0000751_myopathy | 0.85405792 |
| 94 | MP0003705_abnormal_hypodermis_morpholog | 0.85178115 |
| 95 | MP0008569_lethality_at_weaning | 0.83463551 |
| 96 | MP0003283_abnormal_digestive_organ | 0.81756788 |
| 97 | MP0004811_abnormal_neuron_physiology | 0.81706746 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 0.81697414 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 0.81271408 |
| 100 | MP0000747_muscle_weakness | 0.80239326 |
| 101 | MP0009763_increased_sensitivity_to | 0.79803109 |
| 102 | MP0000516_abnormal_urinary_system | 0.79738810 |
| 103 | MP0005367_renal/urinary_system_phenotyp | 0.79738810 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.79360352 |
| 105 | MP0004084_abnormal_cardiac_muscle | 0.79257992 |
| 106 | MP0000639_abnormal_adrenal_gland | 0.75251500 |
| 107 | MP0002557_abnormal_social/conspecific_i | 0.74937096 |
| 108 | MP0005220_abnormal_exocrine_pancreas | 0.74076815 |
| 109 | MP0005334_abnormal_fat_pad | 0.73573356 |
| 110 | MP0003879_abnormal_hair_cell | 0.72280950 |
| 111 | MP0004142_abnormal_muscle_tone | 0.71650814 |
| 112 | MP0009780_abnormal_chondrocyte_physiolo | 0.71086380 |
| 113 | MP0002882_abnormal_neuron_morphology | 0.70730416 |
| 114 | MP0001756_abnormal_urination | 0.70424735 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.70008979 |
| 116 | MP0005670_abnormal_white_adipose | 0.69763283 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.69073314 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.68122282 |
| 119 | MP0005448_abnormal_energy_balance | 0.65118903 |
| 120 | MP0008469_abnormal_protein_level | 0.64084094 |
| 121 | MP0002837_dystrophic_cardiac_calcinosis | 0.62972857 |
| 122 | MP0002090_abnormal_vision | 0.62177995 |
| 123 | MP0006036_abnormal_mitochondrial_physio | 0.61928491 |
| 124 | MP0008874_decreased_physiological_sensi | 0.56231562 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.56017255 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.53611743 |
| 127 | MP0010234_abnormal_vibrissa_follicle | 0.52511351 |
| 128 | MP0003953_abnormal_hormone_level | 0.52492858 |
| 129 | MP0002928_abnormal_bile_duct | 0.52339833 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.52088864 |
| 131 | MP0000579_abnormal_nail_morphology | 0.50407758 |
| 132 | MP0000920_abnormal_myelination | 0.50102218 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.48705884 |
| 134 | MP0002168_other_aberrant_phenotype | 0.48297912 |
| 135 | MP0005266_abnormal_metabolism | 0.47925781 |
| 136 | MP0002909_abnormal_adrenal_gland | 0.46726580 |
| 137 | MP0003075_altered_response_to | 0.46696301 |
| 138 | MP0003633_abnormal_nervous_system | 0.46431461 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.45524832 |
| 140 | MP0005395_other_phenotype | 0.44898117 |
| 141 | MP0003638_abnormal_response/metabolism_ | 0.43053010 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.42718969 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.42618876 |
| 144 | MP0002295_abnormal_pulmonary_circulatio | 0.41553676 |
| 145 | MP0005248_abnormal_Harderian_gland | 0.40605527 |
| 146 | MP0003632_abnormal_nervous_system | 0.38740172 |
| 147 | MP0005166_decreased_susceptibility_to | 0.38088855 |
| 148 | MP0001177_atelectasis | 0.37997764 |
| 149 | MP0003631_nervous_system_phenotype | 0.37874465 |
| 150 | MP0004185_abnormal_adipocyte_glucose | 0.37778602 |
| 151 | MP0008872_abnormal_physiological_respon | 0.37428056 |
| 152 | MP0002796_impaired_skin_barrier | 0.37350169 |
| 153 | MP0006035_abnormal_mitochondrial_morpho | 0.37308375 |
| 154 | MP0001984_abnormal_olfaction | 0.36745966 |
| 155 | MP0004270_analgesia | 0.35652975 |
| 156 | MP0003300_gastrointestinal_ulcer | 0.35614290 |
| 157 | MP0005646_abnormal_pituitary_gland | 0.35297162 |
| 158 | MP0005187_abnormal_penis_morphology | 0.35167002 |
| 159 | MP0005551_abnormal_eye_electrophysiolog | 0.35165391 |
| 160 | MP0004883_abnormal_blood_vessel | 0.34619175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.12842343 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.95503571 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.86667224 |
| 4 | Xanthomatosis (HP:0000991) | 5.98946369 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.95423218 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.94466777 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.67125957 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.27968822 |
| 9 | Complement deficiency (HP:0004431) | 5.12932598 |
| 10 | Epidermoid cyst (HP:0200040) | 4.50719268 |
| 11 | Retinal atrophy (HP:0001105) | 4.33004413 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.27229412 |
| 13 | Hyperammonemia (HP:0001987) | 4.24709205 |
| 14 | Hyperglycinemia (HP:0002154) | 4.20963125 |
| 15 | Ketosis (HP:0001946) | 4.20150087 |
| 16 | Joint hemorrhage (HP:0005261) | 4.18816567 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.14884241 |
| 18 | Fat malabsorption (HP:0002630) | 4.08565438 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.03077469 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.01432124 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.84935776 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.83848645 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.83285784 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.83285784 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.82036134 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.79501971 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79120309 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.77171510 |
| 29 | Hyperglycinuria (HP:0003108) | 3.76579929 |
| 30 | Abnormality of complement system (HP:0005339) | 3.61901706 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.57162831 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.39155417 |
| 33 | Cerebellar dysplasia (HP:0007033) | 3.30999477 |
| 34 | Ketoacidosis (HP:0001993) | 3.28679605 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.18010366 |
| 36 | Increased circulating renin level (HP:0000848) | 3.11435874 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.10137650 |
| 38 | Steatorrhea (HP:0002570) | 3.03515501 |
| 39 | Action tremor (HP:0002345) | 3.01649507 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.00255905 |
| 41 | Myocardial infarction (HP:0001658) | 2.88022649 |
| 42 | Bundle branch block (HP:0011710) | 2.87588811 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.83791097 |
| 44 | Skin nodule (HP:0200036) | 2.83540035 |
| 45 | Pheochromocytoma (HP:0002666) | 2.83172541 |
| 46 | Delayed CNS myelination (HP:0002188) | 2.82688530 |
| 47 | Papillary thyroid carcinoma (HP:0002895) | 2.81959417 |
| 48 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.76040745 |
| 49 | Exercise-induced muscle cramps (HP:0003710) | 2.75241837 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.74794051 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.74170705 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.70894719 |
| 53 | Vascular calcification (HP:0004934) | 2.69131795 |
| 54 | Hypoglycemic seizures (HP:0002173) | 2.68398506 |
| 55 | Gout (HP:0001997) | 2.67278246 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.65849833 |
| 57 | Spontaneous abortion (HP:0005268) | 2.63136866 |
| 58 | Hyporeflexia of lower limbs (HP:0002600) | 2.62411354 |
| 59 | Acanthocytosis (HP:0001927) | 2.60600962 |
| 60 | Metabolic acidosis (HP:0001942) | 2.59043775 |
| 61 | Epileptiform EEG discharges (HP:0011182) | 2.54801716 |
| 62 | Focal motor seizures (HP:0011153) | 2.51573366 |
| 63 | Gowers sign (HP:0003391) | 2.50743332 |
| 64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49492707 |
| 65 | Atonic seizures (HP:0010819) | 2.49385292 |
| 66 | Difficulty climbing stairs (HP:0003551) | 2.48696454 |
| 67 | Neuroendocrine neoplasm (HP:0100634) | 2.47092442 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.46539436 |
| 69 | Sensorimotor neuropathy (HP:0007141) | 2.45726198 |
| 70 | Hypsarrhythmia (HP:0002521) | 2.43669260 |
| 71 | Systemic lupus erythematosus (HP:0002725) | 2.43497529 |
| 72 | Myoglobinuria (HP:0002913) | 2.41510764 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.40251331 |
| 74 | Lethargy (HP:0001254) | 2.38214195 |
| 75 | Mitral stenosis (HP:0001718) | 2.37666098 |
| 76 | Fatigue (HP:0012378) | 2.36434767 |
| 77 | Irritability (HP:0000737) | 2.35127736 |
| 78 | Sudden death (HP:0001699) | 2.33908709 |
| 79 | Frequent falls (HP:0002359) | 2.33324885 |
| 80 | Type II lissencephaly (HP:0007260) | 2.32395305 |
| 81 | Difficulty running (HP:0009046) | 2.30897578 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.30081348 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30081348 |
| 84 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.28630289 |
| 85 | Cholecystitis (HP:0001082) | 2.28049312 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.28049312 |
| 87 | Cholelithiasis (HP:0001081) | 2.26854601 |
| 88 | Scanning speech (HP:0002168) | 2.25458132 |
| 89 | Papilledema (HP:0001085) | 2.25062384 |
| 90 | Hyperventilation (HP:0002883) | 2.24118176 |
| 91 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.22719137 |
| 92 | Neonatal onset (HP:0003623) | 2.20471735 |
| 93 | Glomerulonephritis (HP:0000099) | 2.19993489 |
| 94 | Cerebral edema (HP:0002181) | 2.19922203 |
| 95 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.18136196 |
| 96 | Subaortic stenosis (HP:0001682) | 2.18136196 |
| 97 | Amyloidosis (HP:0011034) | 2.15769612 |
| 98 | Malnutrition (HP:0004395) | 2.15061253 |
| 99 | Atrioventricular block (HP:0001678) | 2.12280244 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09246529 |
| 101 | Blue irides (HP:0000635) | 2.08617073 |
| 102 | Fair hair (HP:0002286) | 2.07982943 |
| 103 | Buphthalmos (HP:0000557) | 2.07748795 |
| 104 | Spastic diplegia (HP:0001264) | 2.07043195 |
| 105 | Hydroxyprolinuria (HP:0003080) | 2.05114496 |
| 106 | Abnormality of proline metabolism (HP:0010907) | 2.05114496 |
| 107 | Abnormal eating behavior (HP:0100738) | 2.04699966 |
| 108 | Pancreatitis (HP:0001733) | 2.04653053 |
| 109 | Hypophosphatemic rickets (HP:0004912) | 2.04497282 |
| 110 | Alkalosis (HP:0001948) | 2.03401008 |
| 111 | Enlarged kidneys (HP:0000105) | 2.03186981 |
| 112 | Intention tremor (HP:0002080) | 2.03096625 |
| 113 | Metabolic alkalosis (HP:0200114) | 2.02998791 |
| 114 | Rickets (HP:0002748) | 2.02992962 |
| 115 | Hyperglycemia (HP:0003074) | 2.02210659 |
| 116 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.01825676 |
| 117 | Neurofibrillary tangles (HP:0002185) | 2.01318382 |
| 118 | Brushfield spots (HP:0001088) | 2.00685738 |
| 119 | Febrile seizures (HP:0002373) | 1.99760230 |
| 120 | Abnormality of the gallbladder (HP:0005264) | 1.99283432 |
| 121 | Esophageal varix (HP:0002040) | 1.97855149 |
| 122 | Tetraparesis (HP:0002273) | 1.97758079 |
| 123 | Thyroid carcinoma (HP:0002890) | 1.97624723 |
| 124 | Hemorrhage of the eye (HP:0011885) | 1.97116052 |
| 125 | Curly hair (HP:0002212) | 1.96974237 |
| 126 | Glycosuria (HP:0003076) | 1.95990614 |
| 127 | Abnormality of urine glucose concentration (HP:0011016) | 1.95990614 |
| 128 | EMG: myopathic abnormalities (HP:0003458) | 1.95154740 |
| 129 | Retinal dysplasia (HP:0007973) | 1.94373345 |
| 130 | Ankle clonus (HP:0011448) | 1.94275813 |
| 131 | Vomiting (HP:0002013) | 1.93734922 |
| 132 | Generalized aminoaciduria (HP:0002909) | 1.92328537 |
| 133 | Syncope (HP:0001279) | 1.91616779 |
| 134 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.90914819 |
| 135 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.90914819 |
| 136 | Limb dystonia (HP:0002451) | 1.90557793 |
| 137 | Status epilepticus (HP:0002133) | 1.90378799 |
| 138 | Akinesia (HP:0002304) | 1.89013083 |
| 139 | Supranuclear gaze palsy (HP:0000605) | 1.87708701 |
| 140 | Abnormality of vision evoked potentials (HP:0000649) | 1.86325623 |
| 141 | Heart block (HP:0012722) | 1.85507715 |
| 142 | Symptomatic seizures (HP:0011145) | 1.84643915 |
| 143 | Late onset (HP:0003584) | 1.82036265 |
| 144 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81894914 |
| 145 | Muscle fiber inclusion bodies (HP:0100299) | 1.81263789 |
| 146 | Nemaline bodies (HP:0003798) | 1.80530180 |
| 147 | Abnormality of the calf musculature (HP:0001430) | 1.79709822 |
| 148 | Drooling (HP:0002307) | 1.79272749 |
| 149 | Polyphagia (HP:0002591) | 1.78868064 |
| 150 | Abnormality of vitamin metabolism (HP:0100508) | 1.78750903 |
| 151 | Renal cortical cysts (HP:0000803) | 1.78251128 |
| 152 | Increased purine levels (HP:0004368) | 1.77887487 |
| 153 | Hyperuricemia (HP:0002149) | 1.77887487 |
| 154 | Hypothermia (HP:0002045) | 1.76696419 |
| 155 | Generalized hypopigmentation of hair (HP:0011358) | 1.76273034 |
| 156 | Menorrhagia (HP:0000132) | 1.74958368 |
| 157 | Abnormality of the corticospinal tract (HP:0002492) | 1.74127618 |
| 158 | Cerebral hemorrhage (HP:0001342) | 1.74060498 |
| 159 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.73158887 |
| 160 | Hemiplegia (HP:0002301) | 1.72339964 |
| 161 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.71917755 |
| 162 | Increased serum pyruvate (HP:0003542) | 1.71757854 |
| 163 | Cerebral inclusion bodies (HP:0100314) | 1.70919978 |
| 164 | Abnormality of glycolysis (HP:0004366) | 1.70876098 |
| 165 | Congenital glaucoma (HP:0001087) | 1.70489048 |
| 166 | Opisthotonus (HP:0002179) | 1.68984092 |
| 167 | Poikilocytosis (HP:0004447) | 1.67650521 |
| 168 | Confusion (HP:0001289) | 1.67155376 |
| 169 | Proximal tubulopathy (HP:0000114) | 1.66817662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.78277342 |
| 2 | INSRR | 3.21108456 |
| 3 | SIK1 | 3.10905908 |
| 4 | FRK | 3.04705349 |
| 5 | FGFR4 | 2.97758763 |
| 6 | TAOK3 | 2.92532585 |
| 7 | ERBB3 | 2.83632398 |
| 8 | ERBB4 | 2.59645526 |
| 9 | TNIK | 2.55617228 |
| 10 | MAP2K4 | 2.53311098 |
| 11 | LATS1 | 2.22257277 |
| 12 | FGFR2 | 2.13049017 |
| 13 | ERN1 | 2.03693351 |
| 14 | OBSCN | 1.97724904 |
| 15 | MAP3K12 | 1.91526958 |
| 16 | PHKG2 | 1.79883829 |
| 17 | PHKG1 | 1.79883829 |
| 18 | DAPK2 | 1.76854626 |
| 19 | STK39 | 1.63814609 |
| 20 | MARK3 | 1.51135534 |
| 21 | EPHA4 | 1.50874756 |
| 22 | MAP3K2 | 1.46344633 |
| 23 | MST1R | 1.40949756 |
| 24 | PIK3CG | 1.40034032 |
| 25 | OXSR1 | 1.38631687 |
| 26 | NEK9 | 1.38618680 |
| 27 | KSR1 | 1.37823470 |
| 28 | NTRK2 | 1.35203510 |
| 29 | MAP3K4 | 1.34712890 |
| 30 | SCYL2 | 1.34401742 |
| 31 | SGK494 | 1.33894827 |
| 32 | SGK223 | 1.33894827 |
| 33 | CAMKK2 | 1.32007418 |
| 34 | EPHB1 | 1.29703832 |
| 35 | STK38L | 1.28517032 |
| 36 | MUSK | 1.25913420 |
| 37 | WNK4 | 1.24122073 |
| 38 | PINK1 | 1.22373720 |
| 39 | PTK2B | 1.21127309 |
| 40 | PNCK | 1.20344267 |
| 41 | BMPR2 | 1.20272793 |
| 42 | ABL2 | 1.15073174 |
| 43 | KSR2 | 1.14534754 |
| 44 | NTRK1 | 1.13310807 |
| 45 | CAMK1D | 1.11932982 |
| 46 | PRKCE | 1.09795228 |
| 47 | SGK3 | 1.09642343 |
| 48 | STK10 | 1.08822344 |
| 49 | YES1 | 1.06375736 |
| 50 | SGK2 | 1.05865267 |
| 51 | RET | 1.05338668 |
| 52 | JAK2 | 1.04787640 |
| 53 | PAK3 | 1.04538120 |
| 54 | MAP4K2 | 1.02654225 |
| 55 | PRKAA2 | 1.01012711 |
| 56 | PLK2 | 1.00605416 |
| 57 | CSNK1G2 | 0.99501440 |
| 58 | LMTK2 | 0.98491838 |
| 59 | CAMK2D | 0.98461776 |
| 60 | MET | 0.98276404 |
| 61 | MAPK11 | 0.95987487 |
| 62 | MAP3K7 | 0.95412634 |
| 63 | CAMK1G | 0.95038700 |
| 64 | RIPK1 | 0.94093198 |
| 65 | PKN1 | 0.92026043 |
| 66 | MAPK13 | 0.91675466 |
| 67 | NEK6 | 0.91417422 |
| 68 | UHMK1 | 0.90982758 |
| 69 | AKT3 | 0.90712473 |
| 70 | ROCK2 | 0.88612605 |
| 71 | JAK1 | 0.87953244 |
| 72 | PRKCZ | 0.87769481 |
| 73 | CAMK2G | 0.86583119 |
| 74 | MOS | 0.83363492 |
| 75 | PDPK1 | 0.82393927 |
| 76 | EPHA3 | 0.81772634 |
| 77 | CSNK1G1 | 0.81666058 |
| 78 | PTK6 | 0.79036824 |
| 79 | STK11 | 0.78385636 |
| 80 | PRKAA1 | 0.77881809 |
| 81 | MAP2K7 | 0.75642830 |
| 82 | PRKCQ | 0.74829445 |
| 83 | CDK5 | 0.74729132 |
| 84 | CSNK1G3 | 0.73682322 |
| 85 | STK24 | 0.72024612 |
| 86 | MAPK15 | 0.68857116 |
| 87 | ERBB2 | 0.67259802 |
| 88 | PRKACG | 0.67102206 |
| 89 | MAP2K1 | 0.66812079 |
| 90 | PDK4 | 0.66700209 |
| 91 | PDK3 | 0.66700209 |
| 92 | PAK6 | 0.66663444 |
| 93 | PRKCH | 0.65926751 |
| 94 | NUAK1 | 0.65879391 |
| 95 | TYK2 | 0.65416654 |
| 96 | MAPK7 | 0.65286924 |
| 97 | CSNK1A1L | 0.65153851 |
| 98 | EPHA2 | 0.64950691 |
| 99 | PTK2 | 0.64715595 |
| 100 | LATS2 | 0.62207920 |
| 101 | NTRK3 | 0.61986466 |
| 102 | CAMKK1 | 0.61632451 |
| 103 | NEK1 | 0.60581452 |
| 104 | MAP3K13 | 0.60367440 |
| 105 | GRK5 | 0.60188553 |
| 106 | EPHB2 | 0.60174794 |
| 107 | FER | 0.59123727 |
| 108 | PRKCG | 0.58559171 |
| 109 | GSK3A | 0.57528269 |
| 110 | IRAK2 | 0.57477582 |
| 111 | MINK1 | 0.56499789 |
| 112 | FGFR3 | 0.56460015 |
| 113 | TRIB3 | 0.56431997 |
| 114 | WNK3 | 0.55764204 |
| 115 | CASK | 0.55571278 |
| 116 | PKN2 | 0.54796385 |
| 117 | PDK1 | 0.54296469 |
| 118 | PBK | 0.53466937 |
| 119 | RPS6KB1 | 0.53029160 |
| 120 | PDK2 | 0.52242671 |
| 121 | SIK2 | 0.52158878 |
| 122 | MAP3K1 | 0.52051516 |
| 123 | IRAK1 | 0.51958966 |
| 124 | DYRK1B | 0.50991328 |
| 125 | MAP3K6 | 0.50800498 |
| 126 | MAP3K9 | 0.48247499 |
| 127 | CAMK2A | 0.48088455 |
| 128 | SGK1 | 0.47915180 |
| 129 | BCR | 0.47868843 |
| 130 | ACVR1B | 0.47646508 |
| 131 | CAMK2B | 0.46613291 |
| 132 | IGF1R | 0.46503604 |
| 133 | TIE1 | 0.46267593 |
| 134 | FLT3 | 0.45689806 |
| 135 | STK38 | 0.45544176 |
| 136 | PIK3CA | 0.45505834 |
| 137 | MAPK12 | 0.45456051 |
| 138 | MAP3K5 | 0.44315180 |
| 139 | MARK1 | 0.44217060 |
| 140 | WNK1 | 0.44084913 |
| 141 | MAP3K14 | 0.43688322 |
| 142 | DYRK1A | 0.43429554 |
| 143 | HIPK2 | 0.41560252 |
| 144 | SIK3 | 0.40146119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.32946010 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.91062413 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.09486203 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06311619 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90543711 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75384182 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57860516 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.51634619 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46757262 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.43382496 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43058835 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38592280 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31600545 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06503462 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.04995124 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.03751527 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02823852 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92836641 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.91500955 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89949023 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87468641 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82166315 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75999049 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75378140 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73743124 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69630687 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63448247 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63221275 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.59856576 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58334981 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.54098944 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52661419 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49947114 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49320613 |
| 35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.43656772 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41562078 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37941674 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33774724 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28863071 |
| 40 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.28111217 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25709940 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24275011 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22496015 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22385818 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.20082351 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17453910 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09579222 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09494836 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09292368 |
| 50 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.06617634 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 1.03620388 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03539698 |
| 53 | Nicotine addiction_Homo sapiens_hsa05033 | 1.02689243 |
| 54 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98237037 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.96169638 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.94448081 |
| 57 | Circadian entrainment_Homo sapiens_hsa04713 | 0.93042185 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92355065 |
| 59 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89974855 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88297097 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87215711 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86997768 |
| 63 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86494995 |
| 64 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.83176867 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.77264405 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77198909 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70514852 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69656530 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68723860 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.66511694 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.63445604 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63068900 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60072700 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60004199 |
| 75 | Long-term depression_Homo sapiens_hsa04730 | 0.59472755 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57933850 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57522290 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55331611 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54331972 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53335327 |
| 81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.52815793 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52591139 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.50066994 |
| 84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48491432 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48049027 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.46742018 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46109368 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44855260 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44533374 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42621120 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41278113 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41167582 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40629007 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39271042 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38318071 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37225493 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34865187 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31813262 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29877639 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.28426800 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27370500 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26952353 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26520443 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17267251 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15140958 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.11151319 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09979428 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.06422159 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.05822736 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.04665765 |
| 111 | GABAergic synapse_Homo sapiens_hsa04727 | 0.04497477 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.03128023 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.02125018 |
| 114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.00270839 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1413738 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1370294 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1276049 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1267835 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1237034 |
| 120 | Cocaine addiction_Homo sapiens_hsa05030 | -0.1191362 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1176903 |
| 122 | Insulin secretion_Homo sapiens_hsa04911 | -0.0916124 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | -0.0858462 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0852959 |
| 125 | Lysosome_Homo sapiens_hsa04142 | -0.0798324 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0326581 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0243133 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0208791 |
| 129 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0063492 |

